Skip to main content

A Phase 1B/2. Multiccenter,Doubleblind Placebo-controlled, Randomized, Single-Ascending dose study to assess the safety, Pharmacokinetics and pharmacodynamics of DS-1040B in Subjects with Acute Ischemic Stroke.

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Neurocritical Care

Awarded By

Daiichi Sankyo Inc

Start Date

February 1, 2016

End Date

December 31, 2019
 

Administered By

Neurology, Neurocritical Care

Awarded By

Daiichi Sankyo Inc

Start Date

February 1, 2016

End Date

December 31, 2019